Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer

NCT04707287 is registered in ClinicalTrials.gov with Liaquat University of Medical & Health Sciences as lead sponsor.

NCT NCT04707287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04707287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Tumour Grade and Sex Steroid Receptor as a Prognostic Index in Breast Cancer
Lead sponsor
Liaquat University of Medical & Health Sciences
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
January 15, 2021
Enrollment
382 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer